Almac expands commercial capabilities to meet industry demand for paediatric formulations
The acquisition reflects growing demand for the specialist packaging solutions for powders, minitabs or granules into stickpack sachets.
Almac Group has expanded its MHRA/FDA-approved UK commercial packaging facility with the acquisition of a stick sachet packaging line from Merz.
The acquisition comes in response to growing demand for the specialist packaging solutions for paediatric drug products, specifically powders, minitabs or granules into stickpack sachets. This investment was made in partnership with a long-term commercial US client who having worked with Almac since 2010, now sought an integrated commercial manufacturing and packaging solution for the EU supply of their new paediatric formulation drug product.
In line with EU Paediatric Regulations (EC1901/2006 and EC1902/2006), the US client implemented its Paediatric Investigation Plan (PIP) and developed and launched an age appropriate formulation to meet infant patient needs; with Almac manufacturing the paediatric granules, primary packing into stickpack sachets and then into wallet cards.
To facilitate the packaging of paediatric dosage forms, investment was made in Merz Stickpack technology. The SBL-50 stickpack technology is a fully automated forming, filling and sealing machine capable of filling 80 stickpacks/minute. This flexible technology not only meets the stickpack presentation needs of Almac’s current clients, it also has capacity to process new paediatric drug products (powders, granules and minitabs) that require this specialist packaging.
David Downey, VP Commercial Operations at Almac commented: “Almac continue to expand our commercial packaging capabilities and the addition of this stickpack solution strengthens Almac’s position in providing flexible services to meet various market needs from small volume orphan drug products to large scale marketed products in both adult and paediatric forms.”
Holger Merz, General Manager at Merz said: “The innovative and committed team at Almac set up a compact, highly flexible packaging solution for micro tablets and powders in stickpacks to service the growing demand for this user-friendly dosage form. Advanced primary packaging forms like stickpacks offer highest flexibility for diversification of pharmaceutical products.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance